Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Challenging Pediatric and Adult Autoimmune Connective Tissue Disease Cases
Description
The presentation discusses complex cases of autoimmune connective tissue diseases, focusing on two particular cases: morphea and dermatomyositis. In the first case, a young girl with morphia presented with undisclosed craniofacial morphia, leading to the utilization of 3D stereo photogrammetry for better assessment of disease progression. The technology allows for detailed volumetric analysis of facial asymmetries, revealing disease activity not always detectable through conventional clinical examinations. The data showed that 3D imaging could both corroborate clinical observations and identify occult disease progression. The second case highlighted a middle-aged woman believed to suffer from a primary vasculitis, but clinical findings indicated she actually had MDA5-associated dermatomyositis, a condition linked to severe complications like rapidly progressive interstitial lung disease. The speaker emphasized the importance of recognizing clinical phenotypes over histological findings for proper diagnosis and treatment. In both cases, effective management strategies were discussed, including medications and interdisciplinary referrals for surgical interventions when necessary. The overarching message was the critical importance of accurate clinical assessment in guiding the care of patients with complex autoimmune disorders.
View moreConclusions
- 3D imaging effectively detects disease progression in craniofacial morphea and corroborates clinical assessments.
- It can identify subtle or occult disease progression that clinical exams may miss.
- Using 3D stereophotogrammetry provides a non-invasive method to track changes over time in patients with craniofacial morphia.
- Limitations include the possibility of atrophy being due to factors other than disease activity.
- In cases of MDA5 dermatomyositis, the clinical phenotype should guide management over serological testing.
- Patients with MDA5 dermatomyositis face a significantly elevated risk of rapidly progressive interstitial lung disease, underscoring the need for timely recognition and intervention.
- Shaw KS, Nguyen TT, Rajeh A, et al. Use of 3-Dimensional Stereophotogrammetry to Detect Disease Progression in Craniofacial Morphea. JAMA Dermatol. Published online October 11, 2023. doi:10.1001/jamadermatol.2023.3649
- Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol. 2011 Jul;65(1):25-34.
- Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis. Arthritis Care Res (Hoboken). 2016 May;68(5):689-94.